10 Facts About Heroin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2019 Ministerial Declaration
COMMISSION ON NARCOTIC DRUGS VIENNA IMPLEMENTATION OF ALL INTERNATIONAL DRUG POLICY COMMITMENTS Follow-up to the 2019 Ministerial Declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem” UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Commission on Narcotic Drugs IMPLEMENTATION OF ALL INTERNATIONAL DRUG POLICY COMMITMENTS Follow-up to the 2019 Ministerial Declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem” UNITED NATIONS Vienna, 2019 © United Nations, July 2019. All rights reserved, worldwide. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Contents 1. Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem ...............................1 2. Outcome document of the thirtieth special session of the General Assembly, entitled “Our joint commitment to effectively addressing and countering the world drug problem” ..................................................9 3. Joint Ministerial Statement of the 2014 High-Level Review by the Commission on Narcotic Drugs of the Implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem ...............................35 4. -
Public Safety Aspects of the Heroin Abuse Epidemic
A brief from June 2015 Public Safety Aspects of the Heroin Abuse Epidemic Overview Policymakers at all levels of government are attempting to address a nationwide increase in heroin abuse.1 Use of the drug has tripled over the past decade, paralleling widespread misuse of prescription opioids, and overdose deaths have increased nearly threefold in the past seven years. Available research suggests that the most effective response to the growth in heroin abuse is a combination of law enforcement to curtail trafficking and limit the emergence of new markets; alternative sentencing to divert nonviolent drug offenders from costly incarceration; treatment to reduce dependency and recidivism; and prevention efforts that can help identify individuals at high risk for addiction. These strategies are most effective when tailored to the specific nature of the heroin problem in a given community. Research further suggests that increasing criminal penalties for heroin-related offenses is unlikely to reverse the growth in heroin use and tends to have a poor return on investment. Figure 1 Heroin Seizures Increased Substantially Starting in 2007 Authorities cite expansion of Mexican production and trafficking 6,000 5,691 kg 5,000 4,000 3,000 2,486 kg 2,000 Heroin seizures (kilograms) 1,000 0 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 ‘10 ‘11 ‘12 ‘13 Source: Office of National Drug Control Policy, 2014 National Drug Control Strategy, “Data Supplement, Table 71,” https://www. whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs_data_supplement_2014.pdf © 2015 The Pew Charitable Trusts Heroin supply on the rise What Is Heroin? Between 2007 and 2013, heroin seizures by federal, state, and local law Heroin is a highly enforcement increased 289 percent.2 (See Figure 1.) U.S. -
Why Medical Cannabis Is Still out of Patients' Reach—An Essay by David
BMJ 2019;365:l1903 doi: 10.1136/bmj.l1903 (Published 1 May 2019) Page 1 of 3 Feature FEATURE BMJ: first published as 10.1136/bmj.l1903 on 1 May 2019. Downloaded from ESSAY Why medical cannabis is still out of patients’ reach—an essay by David Nutt Cannabis has been used as a medicine for millennia, writes David Nutt, who charts its relatively recent prohibition, the effect on patients such as Billy Caldwell, and the failure of legal reform to make much difference David Nutt Edmond J Safra professor of neuropsychopharmacology Imperial College London, London W12 0NN, UK Cannabis is arguably the world’s oldest medicine, with evidence This report was relied on to control cannabis under the 1961 of such use from 3000 year old tombs in Egypt and Siberia. It United Nations Single Convention on Narcotic Drugs and had a place in Indian and Chinese medical writing from nearly amazingly persisted as the international medical guidance on as long ago. It didn’t enter the UK until the late 1600s, but by cannabis until 2018, being used as the justification by the World the 1800s it was widely used, sold over the counter as an Health Organization for keeping cannabis a schedule 1 http://www.bmj.com/ alcoholic tincture for problems such as tetanus and seizures. Its controlled drug till then. Even more absurdly, the 1934 report efficacy more broadly became apparent, and the definitive has been lost, so we can’t explore its evidential base or overview was published in the Lancet in 1890 by John Russell reasoning.3 1 Reynolds. -
Diversion and Illicit Supply of Medicines
ACMD Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Medicines Working Group Secretary: Mohammed Ali 1st Floor (NE), Peel Building 2 Marsham Street London SW1P 4DF Tel: 020 7035 0459 Email: [email protected] Rt Hon. Amber Rudd MP Home Office 2 Marsham Street London SW1P 4DF Rt Hon. Jeremy Hunt MP Department of Health Richmond House 79 Whitehall London SW1A 2NS 15 December 2016 Dear Home Secretary and Secretary of State for Health ACMD report on Diversion and Illicit Supply of Medicines The Advisory Council on the Misuse of Drugs (ACMD) is pleased to enclose its report on Diversion and Illicit Supply of Medicines (referred to as ‘DISM’) for your consideration. This report is in response to the Home Office’s commissioning letter of September 2013, in which the then Home Secretary requested the ACMD to explore the potential for medical and social harms arising from the illicit supply of medicines – predominantly controlled medicines. We are grateful to the ACMD’s stakeholders, who provided presentations at the evidence gathering days as well as helpful written submissions (these are included in a separate attachment, alongside the main report on the ACMD website). This report sets out to: • explore the extent of DISM in the UK, to find out which drugs are being diverted; • evaluate the extent of the medical and social harms of such diversion; and • assess whether DISM displaces or replaces the use of known recreational drugs of abuse, such as heroin. In recent years, DISM has become of increasing public concern across the globe, although the hard evidence for this constituting a major problem other than in the United States is hard to find. -
PSYC 165) Fall 2012
Course Syllabus Drugs, Behavior and Society (PSYC 165) Fall 2012 Instructors: John Monterosso TAs: Lectures: Tue & Thur 8:00 – 9:20 pm, SGM Room 124 FINAL EXAM: Tuesday, December 18 4:30-6:30 p.m. {Note that this is late in the final exam period. If you cannot make this date, please do not take this course.} *Minor revisions may be made to the syllabus – when this occurs, a message will be posted on Blackboard. Drug use can be looked at from many perspectives. Although we will consider several, our emphasis will be on a psychological and physiological perspectives. We want you to leave this course with a better understanding of why people use drugs, what effects drugs have on people, and how individuals think about drug use. Besides learning about drugs and their use, we hope you will learn how to critically evaluate scientific research and the benefits (and limitations) of using this research to inform personal choices and public policy. As a Cat 4 GE class, this larger goal is most important. We recognize that use and abuse of drugs is a topic that touches the everyday lives of people, and we hope this will energize the course. However, please do not look to the faculty or TAs for personal and professional opinions or counsel. Information about available resources is on an informational page posted on Blackboard. Readings The primary course text is: Drugs, Society, and Human Behavior. By Carl Hart & Charles Ksir, 2010. McGraw-Hill 14th edition. It is available for Kindle, and there look to be cheaper options to me at Amazon than the bookstore, but I don’t know what the Bookstore buy-back program is (or if there even is one). -
Perspectives on Opioid and Heroin Use in South Central Pennsylvania
Perspectives on opioid and heroin use in south central Pennsylvania Criminal Justice Trends and initiatives in opioid and heroin abuse: A panel discussion RESEARCH BRIEF The contours of the convened to discuss the issue in 2017-18 Pennsylvania state depth, and to identify current budget (Madej, 2017). problem: Overdose initiatives to address the problem. Narcan is also now widely and death available to citizens over- The panel was comprised of: the-counter. Drug overdoses are the leading Police officers cause of accidental death in the Treatment providers The police officers on the U.S. having surpassed Researchers panel credited equipping shootings and traffic accidents police and other first almost a decade ago (Centers Initiatives responders with Narcan as a for Disease Control and key factor in keeping the opioid overdose death rate Prevention [CDC], 2016). From A key initiative gaining increasing in Pennsylvania from 2014-2015, overdose deaths traction in managing opioid overdose climbing even higher than rose by 11 percent, to 52,404, in Pennsylvania and the greater sixth in the nation, and with roughly 63 percent of region, is the equipping of emergency lauded it as a sort of wonder those deaths involving an medical technicians, police, and other drug. opioid such as heroin, fentanyl, first responders with the opioid or other prescription opioids overdose reversal drug naloxone like Vicodin or Percoset (often (trade name: Narcan), which has been Misconception #1 prescribed legally for routine on the market since 1971. pain management). The Addiction propensity significant increases in drug In 2014, Pennsylvania passed Act overdose deaths were seen While productive discussion 139, which allows first responders ensued, key misconceptions primarily in the northeast, acting at the direction of a health care midwest, and mid-south emerged that were endorsed professional to prescribe Narcan and by several of the panelists. -
The Biden-Harris Administration's Statement of Drug Policy Priorities
EXECUTIVE OFFICE OF THE PRESIDENT OFFICE OF NATIONAL DRUG CONTROL POLICY Washington, DC 20503 The Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One The overdose and addiction crisis has taken a heartbreaking toll on far too many Americans and their families. Since 2015, overdose death numbers have risen 35 percent, reaching a historic high of 70,630 deaths in 2019.1 This is a greater rate of increase than for any other type of injury death in the United States.2 Though illicitly manufactured fentanyl and synthetic opioids other than methadone (SOOTM) have been the primary driver behind the increase, overdose deaths involving cocaine and other psychostimulants, like methamphetamine,3 have also risen in recent years, particularly in combination with SOOTM. New data suggest that COVID-19 has exacerbated the epidemic,4, 5 and increases in overdose mortality6 have underscored systemic inequities in our nation’s approach to criminal justice and prevention, treatment, and recovery. President Biden has made clear that addressing the overdose and addiction epidemic is an urgent priority for his administration. In March, the President signed into law the American Rescue Plan, which appropriated nearly $4 billion to enable the Substance Abuse and Mental Health Services Administration and the Health Resources and Services Administration to expand access to vital behavioral health services. President Biden has also said that people should not be incarcerated for drug use but should be offered treatment instead. The President has also emphasized the need to eradicate racial, gender, and economic inequities that currently exist in the criminal justice system. -
Rethinking America's Illegal Drug Policy
NBER WORKING PAPER SERIES RETHINKING AMERICA'S ILLEGAL DRUG POLICY John J. Donohue III Benjamin Ewing David Peloquin Working Paper 16776 http://www.nber.org/papers/w16776 NATIONAL BUREAU OF ECONOMIC RESEARCH 1050 Massachusetts Avenue Cambridge, MA 02138 February 2011 The authors wish to thank Jonathan Caulkins, Phil Cook, Louis Kaplow, Rob MacCoun, Jeffrey Miron, Peter Reuter, and participants at two NBER conferences and the Harvard Law School Law and Economics workshop for valuable comments. We are also particularly grateful to Jeffrey Miron and Angela Dills for sharing their national time series data on drug prohibition enforcement and crime. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research. © 2011 by John J. Donohue III, Benjamin Ewing, and David Peloquin. All rights reserved. Short sections of text, not to exceed two paragraphs, may be quoted without explicit permission provided that full credit, including © notice, is given to the source. Rethinking America's Illegal Drug Policy John J. Donohue III, Benjamin Ewing, and David Peloquin NBER Working Paper No. 16776 February 2011, Revised March 2011 JEL No. K0 ABSTRACT This paper provides a critical review of the empirical and theoretical literatures on illegal drug policy, including cross-country comparisons, in order to evaluate three drug policy regimes: criminalization, legalization and “depenalization.” Drawing on the experiences of various states, as well as countries such as Portugal and the Netherlands, the paper attempts to identify cost-minimizing policies for marijuana and cocaine by assessing the differing ways in which the various drug regimes would likely change the magnitude and composition of the social costs of each drug. -
Drug Harms in the UK: a Multicriteria Decision Analysis
Articles Drug harms in the UK: a multicriteria decision analysis David J Nutt, Leslie A King, Lawrence D Phillips, on behalf of the Independent Scientifi c Committee on Drugs Summary Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, Published Online policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug November 1, 2010 DOI:10.1016/S0140- harms in the UK. 6736(10)61462-6 See Online/Comment Method Members of the Independent Scientifi c Committee on Drugs, including two invited specialists, met in a DOI:10.1016/S0140- 1-day interactive workshop to score 20 drugs on 16 criteria: nine related to the harms that a drug produces in the 6736(10)62000-4 individual and seven to the harms to others. Drugs were scored out of 100 points, and the criteria were weighted to Neuropsychopharmacology indicate their relative importance. Unit, Imperial College, London, UK (Prof D J Nutt FMedSci); UK Expert Adviser to the European Findings MCDA modelling showed that heroin, crack cocaine, and metamfetamine were the most harmful drugs to Monitoring Centre for Drugs individuals (part scores 34, 37, and 32, respectively), whereas alcohol, heroin, and crack cocaine were the most harmful and Drug Addiction (EMCDDA), to others (46, 21, and 17, respectively). Overall, alcohol was the most harmful drug (overall harm score 72), with Lisbon, Portugal (L A King PhD); heroin (55) and crack cocaine (54) in second and third places. and Department of Management, London School of Economics and Political Interpretation These fi ndings lend support to previous work assessing drug harms, and show how the improved scoring Science, London, UK and weighting approach of MCDA increases the diff erentiation between the most and least harmful drugs. -
FOR IMMEDIATE RELEASE CONTACT Voleine Amilcar 415
FOR IMMEDIATE RELEASE CONTACT Voleine Amilcar 415-356-8383 x 244 [email protected] Mary Lugo 770-623-8190 [email protected] Cara White 843-881-1480 [email protected] For downloadable images, visit pbs.org/pressroom/ THE HOUSE I LIVE IN PREMIERES ON INDEPENDENT LENS ON MONDAY, APRIL 8, 2013 “I’d hate to imply that it’s your civic duty to see The House I Live In, but guess what — it is.” — Ty Burr, The Boston Globe (San Francisco, CA) — Winner of the Grand Jury Prize at the Sundance Film Festival, Eugene Jarecki’s The House I Live In builds a compelling case for the complete failure of America’s war on drugs. For the past forty years, the war on drugs has resulted in more than 45 million arrests, one trillion dollars in government spending, and America’s role as the world’s largest jailer. Yet for all that, drugs are cheaper, purer, and more available than ever. Filmed in more than twenty states, The House I Live In captures heart-wrenching stories from those on the front lines — from the dealer to the grieving mother, the narcotics officer to the senator, the inmate to the federal judge — and offers a penetrating look at the profound human rights implications of America’s longest war. The House I Live In premieres on Independent Lens, hosted by Stanley Tucci, on Monday, April 8, 2013 at 10 PM on PBS (check local listings). The film recognizes drug abuse as a matter of public health, and investigates the tragic errors and shortcomings that have resulted from framing it as an issue for law enforcement. -
The Drugs of War—Captagon and the Islamic State
REPORT CRIMINAL JUSTICE The Drugs of War—Captagon and the Islamic State APRIL 15, 2016 — PATRICK RADDEN KEEFE PAGE 1 One perennial challenge of writing about illicit narcotics is the dearth of hard data. While drug-trafficking organizations often maintain scrupulous records of their transactions, they have a pronounced disincentive to open these books to outsiders. And for a variety of reasons, the media, the counterdrug law-enforcement establishment, and elected political leaders all have incentives to overplay the problem. In a dismayingly typical scenario, drug warriors will fill this information vacuum by conjuring up back-of-the-envelope figures, which the press will then gleefully repeat—at which point, the drug warriors will seek a budget increase, citing the press account, which has now accorded their data points the aura of established fact. (This configuration of mutually affirming incentives is sometimes described—by federal bureaucrats who are clear-eyed enough to admit it—as a self- licking ice cream cone.) If there is fog in the drug war, there is more still in the actual armed conflagration that has consumed Syria, which is now entering its fifth year. And the violent fluidity of this conflict makes it all the more difficult to assess a wave of reports over the past several years about the significance of a little pill known as Captagon—an amphetamine that is said to play a significant part in the civil war. According to numerous accounts, Captagon has become immensely popular with the fighters of the Islamic State. According to numerous accounts, Captagon has become immensely popular with the fighters of the Islamic State. -
Mind Medicine Australia’S Submission to the Royal Commission Into Victoria’S Mental Health System
SUB.0002.0029.0347 Mind Medicine Australia’s Submission to The Royal Commission into Victoria’s Mental Health System 5th July 2019 “...My hope is that we will engage in mature, evidence-based discussions about how best to fund and deploy psychedelic-assisted psychotherapies to augment existing approaches to the treatment of mental illness. I hope that governments will have the courage to put the welfare of their citizens ahead of their fear of controversy ‒ and that our politicians will deploy their considerable skills and positions of influence to nurture a balanced and objective understanding amongst the public.” ‒ Dr Simon Longstaff AO, Leading Australian Ethicist and Executive Director of The Ethics Centre Royal Commission into Victoria’s Mental Health System | Mind Medicine Australia SUB.0002.0029.0347_0002 Level 1, 10 Dorcas St Southbank, VIC 3006 Australia 5th July 2019 The Commissioners The Royal Commission into Victoria’s Mental Health System Dear Commissioners We live in one of the wealthiest countries and we have one of the best medical systems in the world. Yet despite the high calibre of our medical practitioners and institutions, and the enormous associated system costs, we also have one of the highest rates of mental illness in the world, and the situation appears to be getting worse. Simply doing more of the same, or making only incremental changes to the current system, is not going to solve this problem and relieve the suffering of so many Victorians. To create positive change, we have to broaden the tools available to our medical practitioners and qualified therapists in this area.